Compare · DFTX vs USNA
DFTX vs USNA
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and USANA Health Sciences Inc. (USNA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DFTX and USNA operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- DFTX is the larger of the two at $2.51B, about 7.3x USNA ($345.3M).
- USNA has been more active in the news (9 items in the past 4 weeks vs 3 for DFTX).
- DFTX has more recent analyst coverage (4 ratings vs 3 for USNA).
- Company
- Definium Therapeutics Inc.
- USANA Health Sciences Inc.
- Price
- $23.02-2.29%
- $18.80+4.50%
- Market cap
- $2.51B
- $345.3M
- 1M return
- -
- -3.64%
- 1Y return
- -
- -36.89%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 3
- 9
- Recent ratings
- 4
- 3
USANA Health Sciences Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Latest DFTX
- Definium Therapeutics Announces New Employee Inducement Grants
- Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
- Definium Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Definium Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
- Definium Therapeutics Announces New Employee Inducement Grants
- SEC Form 10-Q filed by Definium Therapeutics Inc.
- Definium Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
- Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
Latest USNA
- CHIEF PEOPLE OFFICER Jones Paul A. sold $102,878 worth of shares (5,561 units at $18.50), closing all direct ownership in the company (SEC Form 4)
- USANA's Celavive Contouring Face & Neck Crème Named Among Canada's Top Skincare Products
- USANA Earns Dual Best of State Honors for Product Innovation and Development
- Director Fleming John Turman sold $43,928 worth of shares (2,450 units at $17.93), decreasing direct ownership by 37% to 4,230 units (SEC Form 4)
- Kevin Guest Encourages Professionals to Prioritize Wellness During Professional Wellness Month
- CHIEF PEOPLE OFFICER Jones Paul A. sold $129,106 worth of shares (6,813 units at $18.95), decreasing direct ownership by 55% to 5,561 units (SEC Form 4)
- CHIEF FINANCIAL OFFICER Iiekking G Doug sold $100,513 worth of shares (5,360 units at $18.75), closing all direct ownership in the company (SEC Form 4)
- Director Fuller Gilbert A sold $19,729 worth of shares (1,057 units at $18.66), closing all direct ownership in the company (SEC Form 4)
- USANA Health Sciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 10-Q filed by USANA Health Sciences Inc.